BRPI0515891A - método para produzir um produto em aerossol medicinal, e, produto em aerossol medicinal - Google Patents

método para produzir um produto em aerossol medicinal, e, produto em aerossol medicinal

Info

Publication number
BRPI0515891A
BRPI0515891A BRPI0515891-5A BRPI0515891A BRPI0515891A BR PI0515891 A BRPI0515891 A BR PI0515891A BR PI0515891 A BRPI0515891 A BR PI0515891A BR PI0515891 A BRPI0515891 A BR PI0515891A
Authority
BR
Brazil
Prior art keywords
aerosol product
medical aerosol
producing
medical
product
Prior art date
Application number
BRPI0515891-5A
Other languages
English (en)
Inventor
Kevin J Bechtold
John T Capecchi
Robert S Davidson
Sarah B Gunderson
Original Assignee
3 M Innovative Properties Comp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 M Innovative Properties Comp filed Critical 3 M Innovative Properties Comp
Publication of BRPI0515891A publication Critical patent/BRPI0515891A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA PRODUZIR UM PRODUTO EM AEROSSOL MEDICINAL, E, PRODUTO EM AEROSSOL MEDICINAL". Um produto em aerossol medicinal e processo, tal como para um inalador de dose medida HFA, em que pelo menos um dos ingredientes da formulação é sintetizado, realizando-se pelo menos parte da reação química para produzir os ingredientes em um meio de reação de hidrofluoroalcano.
BRPI0515891-5A 2004-09-24 2005-09-06 método para produzir um produto em aerossol medicinal, e, produto em aerossol medicinal BRPI0515891A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61306304P 2004-09-24 2004-09-24
PCT/US2005/031716 WO2006036473A1 (en) 2004-09-24 2005-09-06 Medicinal aerosol formulations and methods of synthesizing ingredients therefor

Publications (1)

Publication Number Publication Date
BRPI0515891A true BRPI0515891A (pt) 2008-08-12

Family

ID=36119215

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515891-5A BRPI0515891A (pt) 2004-09-24 2005-09-06 método para produzir um produto em aerossol medicinal, e, produto em aerossol medicinal

Country Status (9)

Country Link
US (1) US20070286815A1 (pt)
EP (1) EP1807122A4 (pt)
JP (1) JP2008514600A (pt)
CN (1) CN101027088A (pt)
AU (1) AU2005290068A1 (pt)
BR (1) BRPI0515891A (pt)
CA (1) CA2581575A1 (pt)
MX (1) MX2007003468A (pt)
WO (1) WO2006036473A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007011161A (es) * 2005-03-14 2007-11-13 3M Innovative Properties Co Compuestos polimericos biocompatibles para formulaciones medicinales.
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
JP2014532717A (ja) * 2011-11-03 2014-12-08 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． 反応性噴射剤を使用した安定な皮膚用エアゾールフォーム
WO2015195711A2 (en) * 2014-06-16 2015-12-23 Shurtleff, James, Kevin Method and devices for manufacturing and delivering of aerosolized formulations
US9452178B1 (en) * 2014-10-22 2016-09-27 SatisPharma, LLC Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328808D0 (en) * 1983-10-28 1983-11-30 Riker Laboratories Inc Inhalation responsive dispensers
US4819834A (en) * 1986-09-09 1989-04-11 Minnesota Mining And Manufacturing Company Apparatus and methods for delivering a predetermined amount of a pressurized fluid
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
JP3172190B2 (ja) * 1993-07-15 2001-06-04 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医薬エアロゾルを配給するための器具
US5478910A (en) * 1995-03-01 1995-12-26 Bayer Corporation Process for the production of polyesters using enzymes and supercritical fluids
KR19980702911A (ko) * 1995-03-10 1998-09-05 테릴 케이. 퀄리 에어로졸 밸브
US6126919A (en) * 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
GB9718740D0 (en) * 1997-09-05 1997-11-12 Advanced Phytonics Ltd Improvements in or relating to the preparation of a compound
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6080899A (en) * 1999-01-25 2000-06-27 Alliedsignal Inc. Method of producing fluorinated organic compounds
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
TW503997U (en) * 2001-12-14 2002-09-21 Hon Hai Prec Ind Co Ltd Optical switch device
KR100503890B1 (ko) * 2002-10-08 2005-07-26 한국과학기술연구원 생분해성 폴리에스테르 중합체 및 압축기체를 이용한 이의제조방법
EP1699847B1 (en) * 2003-12-30 2011-04-13 3M Innovative Properties Company Method for the preparation of medicinal compositions

Also Published As

Publication number Publication date
CA2581575A1 (en) 2006-04-06
EP1807122A4 (en) 2009-04-22
CN101027088A (zh) 2007-08-29
EP1807122A1 (en) 2007-07-18
MX2007003468A (es) 2007-05-18
WO2006036473A1 (en) 2006-04-06
JP2008514600A (ja) 2008-05-08
AU2005290068A1 (en) 2006-04-06
US20070286815A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
BR0010456A (pt) Uso de xenÈnio para tratar neurointoxicações, preparação inalável e método para produzir uma preparação inalável
DE60308997D1 (de) Formulierungen zur inhalation
BR0315166A (pt) Uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, que necessita de tratamento
BR0312464A (pt) Inibidores de tirosina quinases
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BRPI0318811B8 (pt) derivados de ciclohexanol espirocíclicos
TW200510375A (en) New compounds
IT1317846B1 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
DE122011100049I1 (de) Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen.
BRPI0507604A (pt) medicamentos com atividade de receptor hm74a
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
BR0313526A (pt) Medicamento inalativos que contêm um agente anticolinérigo, em combinação com corticoesteróides e betamiméticos
CY1109519T1 (el) Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου
UY27757A1 (es) Medicamento que contiene betamiméticos y un nuevo anticolinérgico.
BR0112322A (pt) Nova formulação aerossol contendo uma molécula fluorada polar
BR0211601A (pt) Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos
BR0311940A (pt) Difenilazetidinonas substituìdas no anel, processo para produção das mesmas, medicamentos que contêm esses compostos e uso dos mesmos
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
DE602004015406D1 (de) Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen
PT1124841E (pt) Fenil-alcenoil-guanidinas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como composicao farmaceutica que as contem
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
BR0309085A (pt) Medicamento que contém esteróides e agente anticolinérgico
BRPI0509238A (pt) processo e dispositivo para administração de xenÈnio a pacientes
MX2007003468A (es) Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.